{"transactions":[{"id":2383388,"issuer":{"id":7609,"kind":"organization","name":"Marker Therapeutics, Inc."},"owners":[{"id":130160,"kind":"person","name":"Garrett Gerald","position":1,"cik":"0001804510","reported_name":"Garrett Gerald","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice President, Clinical Ops."}}],"security":"Employee Stock Option (right to buy)","published_at":"2022-02-22T17:02:51.000Z","date":"2022-02-17","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests in equal monthly installments over a four year period commencing on March 17, 2022 subject to the continued service by the Reporting Person to the Issuer as of the applicable vesting date."}],"balance_after":40000,"derivative":{"exercise_price":0.46,"expiration_date":"2032-02-17","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001209191-22-011761","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1804510/000120919122011761/doc4.xml","form_type":"4"}},{"id":2864517,"issuer":{"id":7609,"kind":"organization","name":"Marker Therapeutics, Inc."},"owners":[{"id":130160,"kind":"person","name":"Garrett Gerald","position":1,"cik":"0001804510","reported_name":"Garrett Gerald","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice President, Clinical Ops."}}],"security":"Employee Stock Option (right to buy)","published_at":"2021-02-12T17:23:29.000Z","date":"2021-02-10","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests in equal monthly installments over a four year period commencing on March 10, 2021 subject to the continued service by the Reporting Person to the Issuer as of the applicable vesting date."}],"balance_after":40000,"derivative":{"exercise_price":3.29,"expiration_date":"2031-02-10","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001209191-21-010262","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1804510/000120919121010262/doc4.xml","form_type":"4"}},{"id":3214227,"issuer":{"id":7609,"kind":"organization","name":"Marker Therapeutics, Inc."},"owners":[{"id":130160,"kind":"person","name":"Garrett Gerald","position":1,"cik":"0001804510","reported_name":"Garrett Gerald","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice President, Clinical Ops."}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2020-03-12T16:36:42.000Z","date":"2020-03-10","kind":"grant","acquired":true,"shares":38300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option vests in equal monthly installments over a four year period commencing on April 10, 2020 subject to the continued service by the Reporting Person to the Issuer as of the applicable vesting date."}],"balance_after":38300,"derivative":{"exercise_price":2.12,"expiration_date":"2030-03-10","underlying":"Common Stock","underlying_shares":38300},"source":{"system":"sec-edgar","filing":"0001209191-20-018528","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1804510/000120919120018528/doc4.xml","form_type":"4"}},{"id":3214226,"issuer":{"id":7609,"kind":"organization","name":"Marker Therapeutics, Inc."},"owners":[{"id":130160,"kind":"person","name":"Garrett Gerald","position":1,"cik":"0001804510","reported_name":"Garrett Gerald","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice President, Clinical Ops."}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2020-03-12T16:36:42.000Z","date":"2020-03-10","kind":"grant","acquired":true,"shares":1700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents a bonus for 2019 performance granted under the Company's 2014 Omnibus Stock Ownership Plan. This option vests in equal monthly installments over a four year period commencing on April 10, 2020 subject to the continued service by the Reporting Person to the Issuer as of the applicable vesting date."}],"balance_after":1700,"derivative":{"exercise_price":2.12,"expiration_date":"2030-03-10","underlying":"Common Stock","underlying_shares":1700},"source":{"system":"sec-edgar","filing":"0001209191-20-018528","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1804510/000120919120018528/doc4.xml","form_type":"4"}}]}